Elenfare Pharmaceuticals is a pharmaceutical company based in New York, New York, specializing in the development and distribution of medicinal products. Situated at 45 W 123rd St in the 10027 postal area, this company serves the local community with a range of pharmaceutical solutions designed to meet diverse healthcare needs. The facility is equipped to handle various stages of pharmaceutical production, from research and formulation to packaging and delivery.
Operating within the highly regulated pharmaceutical industry, Elenfare Pharmaceuticals focuses on maintaining strict quality control standards to ensure the safety and efficacy of its products. The company’s operations involve collaboration with healthcare providers and suppliers to facilitate the availability of essential medications. Their presence in New York positions them strategically within a major hub for medical innovation and healthcare services.
Elenfare Pharmaceuticals also contributes to the local economy by providing employment opportunities in pharmaceutical manufacturing and related fields. The company’s commitment to compliance with industry regulations underscores its role as a responsible entity in the pharmaceutical sector. By adhering to best practices in drug development and distribution, Elenfare Pharmaceuticals supports the broader healthcare infrastructure in New York City and beyond.
The company’s location in a densely populated urban area allows for efficient logistics and distribution channels, ensuring timely delivery of pharmaceutical products. Elenfare Pharmaceuticals remains focused on addressing the evolving needs of patients and healthcare professionals through consistent product availability and operational reliability. Their continued presence in New York highlights their role as a key player in the regional pharmaceutical landscape.


































